nicotine has been researched along with okadaic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| O'Shea, SM; Ochoa, EL | 1 |
| Berg, DK; Romano, SJ; Rothhut, B; Vijayaraghavan, S | 1 |
| Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
| Guan, X; Nakauchi, S; Sumikawa, K | 1 |
| Bunch, TD; Li, GP; Liu, Y; Sessions, BR; White, KL; Yang, S | 1 |
| Arribas, RL; Bordas, A; Cedillo, JL; de Los Ríos, C; Domènech Omella, J; Janssens, V; Montiel, C | 1 |
6 other study(ies) available for nicotine and okadaic acid
| Article | Year |
|---|---|
Concomitant protein phosphorylation and endogenous acetylcholine release induced by nicotine: dependency on neuronal nicotinic receptors and desensitization.
Topics: Acetylcholine; Animals; Atropine; Bungarotoxins; Calcium; Cell Membrane; Ethers, Cyclic; Exocytosis; Frontal Lobe; Male; Mecamylamine; Membrane Potentials; Nerve Tissue Proteins; Nicotine; Nicotinic Antagonists; Okadaic Acid; omega-Agatoxin IVA; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Spider Venoms; Synapsins; Synaptosomes; Veratridine | 1994 |
Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Animals; Cells, Cultured; Colforsin; Cycloheximide; Ethers, Cyclic; Isoquinolines; Mice; Nicotine; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Receptors, Cholinergic; Sulfonamides | 1996 |
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |
Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region.
Topics: Aconitine; Analysis of Variance; Animals; Dihydro-beta-Erythroidine; Dose-Response Relationship, Radiation; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Ethers, Cyclic; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Okadaic Acid; Oxazoles; Rats; Rats, Sprague-Dawley | 2006 |
Nicotine combined with okadaic acid or taxol adversely affects bovine oocyte maturation and subsequent embryo development.
Topics: Animals; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Embryonic Development; Female; Nicotine; Okadaic Acid; Oocytes; Paclitaxel | 2009 |
An okadaic acid fragment analogue prevents nicotine-induced resistance to cisplatin by recovering PP2A activity in non-small cell lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Lung Neoplasms; Models, Molecular; Molecular Docking Simulation; Nicotine; Okadaic Acid; Protein Phosphatase 2 | 2020 |